Actithera draws new investors to radiopharma drug pitch
BioPharma Drive: Drug Pricing
JULY 9, 2025
M Ventures, which helped found the company in 2021, co-led the Series A round with Hadean Ventures, Sofinnova Partners and 4BIO Capital. The technology works by attaching a radioisotope to a targeting compound via a specially engineered “linker” molecule. Five other firms also participated.
Let's personalize your content